Sun R, Yu P, Guo L, Huang Y, Nie Y, Yang Y
If your baseline B12 is already adequate, MIC B12 injections target metabolic support rather than deficiency correction, making proper storage even more critical for consistent benefit
Introduction We focused on the stable gastric pentadecapeptide BPC 157 ( Thus, we suggest that one single application of the NO-synthase (NOS) blocker N(G)-nitro-L-arginine methyl ester (L-NAME) may induce retinal ischemia in rats, and that the stable pentadecapeptide BPC 157 may be the therapy, since it may interact with the NO-system and may counteract various adverse effects of L-NAME application (see In the previous eye research studies, BPC 157 counteracts atropine-mydriasis, but it also opposes an immediate and hour-lasting miotic effect of L-NAME in rats and guinea pigs, and participates in pupil control potentially via NO-mediated and cholinergic mechanisms ( This may be essential for the effective counteraction of the damaging effect of the retrobulbar L-NAME application
Limitations: It is not a direct antioxidant like Vitamin C
Other areas for heightened scrutiny involve payment processor transaction flags for high risk medical or wellness services such as peptide therapy
Step 3 reconstitute and draw